Strategy

Moving beyond the amyloid beta hypothesis, by Jean-Claude Muller

Read more

Trends in investment for cell and gene therapies

Read more

Research Strategy, PharmNovo develops new opioid for chronic pain, by Per von Mentzer

Read more

Achieving federated analysis through partnership, by Philip Quinlan

Read more

MicroRNA as a source of drugs for obesity, Interview with Resalis Therapeutics

Read more

Obesity Review, New drugs and new indications in the clinic, by Peter Charlish

Read more

European biopharma forecasts for 2024

Read more

Caszyme pioneers gene editing from Lithuania

Read more

Zealand Pharma maps out strategy for obesity

Read more

The weight loss sector continues to evolve

Read more